A platform for research: civil engineering, architecture and urbanism
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy (Adv. Sci. 16/2022)
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy (Adv. Sci. 16/2022)
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy (Adv. Sci. 16/2022)
Ma, Jie (author) / Li, Wei (author) / Cao, Ruiyuan (author) / Gao, Dunqin (author) / Zhang, Qiyu (author) / Li, Xiao (author) / Li, Biyou (author) / Lv, Luye (author) / Li, Mansheng (author) / Jiang, Junyi (author)
Advanced Science ; 9
2022-05-01
1 pages
Article (Journal)
Electronic Resource
English
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy
Wiley | 2022
|Treatment of Localized and Systemic Scleroderma
British Library Conference Proceedings | 2002
|Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs
Wiley | 2020
|